Fabry and Cardiomyopathy (FaCard) Epidemiological Study for the Analysis of Biomarkers and the Clinical Course of Patients With Fabry Disease and the N215S-mutation "FaCard"

Recruiting

Phase N/A Results N/A

Summary of Purpose

Primary objective and endpoint is the analysis of the long-term course of lyso-Gb3 and its clinical correlation to the progression of the cardiomyopathy in N215S-Fabry patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 June 2017.

1 Aug 2011 6 Sep 2011 1 Aug 2019 1 Sep 2019 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts